Updated Patient Resource for Colon Cancer Available on NCCN.org/patients
By Laura Hanisch, PsyD, Medical Writer/Patient Information Specialist
The updated 2014 Version of the NCCN Guidelines for Patients®: Colon Cancer is available to view and download on NCCN.org/patients; users can also order print versions of this patient resource.
The NCCN Guidelines for Patients®: Colon Cancer is a high-quality resource for patients and caregivers in the process of planning or receiving treatment. It includes the most recent test and treatment recommendations for each stage of the disease. Outlined explanations of the most recent updates for colon cancer are also available to view on NCCN.org/patients.
Major changes in the 2014 Version are based on recent research. For use of cetuximab or panitumumab, the NCCN Guidelines for Patients®: Colon Cancer recommends testing of genes that control KRAS and NRAS proteins is needed. If these genes are abnormal, neither drug should be used. FOLFOXIRI plus bevacizumab is a new option for stage IV colon cancer that has spread to the liver, lungs, or both and can’t be treated with surgery. For advanced colon cancer, regorabenib is a new option for patients who have tried all other drug treatments.
The National Comprehensive Cancer Network® (NCCN®) aims to provide people with cancer and the general public with state-of-the-art cancer treatment information in easy-to-understand language. The NCCN Guidelines for Patients®, translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), are meant to help patients with cancer talk to their doctors about the best treatment options for the type of cancer that they have.
The NCCN Guidelines for Patients are developed according to plain language principles to improve health literacy. The design and format feature patient-friendly elements such as medical illustrations alongside descriptions of body parts, tests, and treatment. They also include an expansive glossary of medical terms and acronyms.
NCCN currently offers NCCN Guidelines for Patients for the following: Breast, Colon, Esophageal, Non-Small Cell Lung, Ovarian, Pancreatic, and Prostate Cancers; Caring for Adolescents and Young Adults (AYA); Chronic Myelogenous Leukemia; Lung Cancer Screening; Malignant Pleural Mesothelioma; Melanoma; and Multiple Myeloma.
Funding for the library of NCCN Guidelines for Patients is made possible through the NCCN Foundation®.
For more information or to view the NCCN Guidelines for Patients®: Colon Cancer, visit NCCN.org/patients.